Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery



Rating:

Share or cite this content

Citations should be made in the following way:
T. Joan, A. Martin (ainamartin89@gmail.com / Inflammation, R. and Cancer in Respiratory Diseases, B. Islands Health Research Institute (IdISBa),Palma), A. Jahn (a.jahn@animalstemcare.com / Inflammation, R. and Cancer in Respiratory Diseases, B. Islands Health Research Institute (IdISBa),Palma), C. Rio (crio.ssib@gmail.com / Inflammation, R. and Cancer in Respiratory Diseases, B. Islands Health Research Institute (IdISBa),Palma), E. Sala (ernest.sala@ssib.es / Inflammation, R. and Cancer in Respiratory Diseases, B. Islands Health Research Institute (IdISBa),Palma), J. Mercader (josep.mercader@uib.es / Inflammation, R. and Cancer in Respiratory Diseases, B. Islands Health Research Institute (IdISBa); Department of Fundamental Biology and Health Sciences, U. of the Balearic Islands; Foners Veterinary Medicine And Innovation SLP,Palma). LSC - 2021 - Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis. 3695

Member's Comments

No comment yet.

Related content which might interest you: PP238 – Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis Source: ERS Lung Science Conference 2021 Year: 2021 LSC - 2020 - Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis patients Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 LSC - 2021 - Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Abnormal proliferation and differentiation of c-kit+ lung stem cells in pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 LSC - 2021 - Effect of elexacaftor-tezacaftor-ivacaftor on pulmonary and endothelial function in a patient with advanced cystic fibrosis Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis Year: 2021 Impaired migration of bone marrow mesenchymal stem cells in COPD Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Increased TERT mRNA expression of bone marrow mesenchymal stem cells (BM-MSCs) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Thyroid hormone inhibits pulmonary fibrosis through enhancement of mitochondrial function in alveolar epithelial cells Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 The secretome of induced pluripotent stem cells (iPSC) modulates macrophage phenotype in the fibrotic lung Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids Source: ERS Lung Science Conference 2021 Year: 2021 Epithelial stem cells at the intersection of tissue regeneration and pulmonary fibrosis Source: Eur Respir Monogr 2021; 91: 290-305 Year: 2021 Oral presentation: Increased CXCR4 expression and short telomeres in bone marrow mesenchymal stem cells of patients with idiopathic pulmonary fibrosis Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 Increased CXCR4 expression and short telomeres in bone marrow mesenchymal stem cells of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009 Results immunophenotyping cultured autologous mesenchymal stromal cell of patients with COPD and IPF in Belarus Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases Year: 2015 Identification and characterization of mesenchymal stem cells in the human lung Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells Source: Eur Respir J 2012; 39: 446-457 Year: 2012 Expression of the biological axis VEGF-CXCL12/CXCR4 in bone marrow mesenchymal stem cells (BM MSCs) in patients with idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis Year: 2008 The enhancement of Stanniocalcin-1 (STC1) secretion increases the ability of mesenchymal stem cells (MSCs) to reduce bleomycin-induced lung fibrosis in a mouse model through inhibition of endoplasmic reticulum stress (ER-stress)/TGFbeta1 pathway Source: International Congress 2014 – ILDs 1 Year: 2014